| - GRCh37:
- Chr1:161275946
- GRCh38:
- Chr1:161306156
| MPZ | K199N | Charcot-Marie-Tooth disease type 2I | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr1:161276240
- GRCh38:
- Chr1:161306450
| MPZ | G155R | Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D | Uncertain significance (Jan 1, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161276634
- GRCh38:
- Chr1:161306844
| MPZ | D104E | Inborn genetic diseases, not provided, Charcot-Marie-Tooth disease type 2I
| Uncertain significance (Oct 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161279637
- GRCh38:
- Chr1:161309847
| MPZ, SDHC | S20F | Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease dominant intermediate D
| Uncertain significance (Nov 30, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161275751
- GRCh38:
- Chr1:161305961
| MPZ | A221V | Charcot-Marie-Tooth disease, type I | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:161276549
- GRCh38:
- Chr1:161306759
| MPZ | P133T | Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 2J, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease, type I | Pathogenic/Likely pathogenic (Jul 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161277179
- GRCh38:
- Chr1:161307389
| MPZ | D35N | not provided, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2I
| Pathogenic (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161275705-161275707
- GRCh38:
- Chr1:161305915-161305917
| MPZ | K236del | Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I, Inborn genetic diseases, Charcot-Marie-Tooth disease type 2I, not provided | Conflicting interpretations of pathogenicity (Jan 9, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161277149
- GRCh38:
- Chr1:161307359
| MPZ | R45W | Charcot-Marie-Tooth disease, type I, Inborn genetic diseases, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Dejerine-Sottas disease, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 4E, not provided | Conflicting interpretations of pathogenicity (Oct 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161276252
- GRCh38:
- Chr1:161306462
| MPZ | P151T | Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome, Dejerine-Sottas disease, not provided
| Conflicting interpretations of pathogenicity (Sep 2, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161275943
- GRCh38:
- Chr1:161306153
| MPZ | | Neuropathy, congenital hypomyelinating, 2, Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 1B, not specified, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D, Roussy-Lévy syndrome | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161276599
- GRCh38:
- Chr1:161306809
| MPZ | N116S | not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease, type I | Uncertain significance (Oct 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161276702
- GRCh38:
- Chr1:161306912
| MPZ | Y82H | Charcot-Marie-Tooth disease, type I, not provided, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease dominant intermediate D | Pathogenic/Likely pathogenic (Oct 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161277096
- GRCh38:
- Chr1:161307306
| MPZ | I62M | Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2I, Roussy-Lévy syndrome
| Conflicting interpretations of pathogenicity (Mar 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161277104
- GRCh38:
- Chr1:161307314
| MPZ | D60H | Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 1B | Conflicting interpretations of pathogenicity (Aug 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:161276512
- GRCh38:
- Chr1:161306722
| MPZ | Y145S | MPZ-related condition, Charcot-Marie-Tooth disease type 4E, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 2I, Dejerine-Sottas disease, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease, type I, not provided | Pathogenic (Mar 29, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161277151
- GRCh38:
- Chr1:161307361
| MPZ | S44F | Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease, type I, Inborn genetic diseases, not provided | Pathogenic (Jul 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161276672
- Chr1:161276217
- Chr1:161276680
- GRCh38:
- Chr1:161306882
- Chr1:161306427
- Chr1:161306890
| MPZ, MPZ, MPZ | V92M, I162M, I89N | Charcot-Marie-Tooth disease type 2I | Pathogenic (Feb 1, 2002) | no assertion criteria provided |
| - GRCh37:
- Chr1:161276575
- GRCh38:
- Chr1:161306785
| MPZ | T124M | Charcot-Marie-Tooth disease, type I, Charcot-Marie-Tooth disease type 2I, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 4E, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease type 1B, Inborn genetic diseases, not provided, Charcot-Marie-Tooth disease dominant intermediate D ...see more | Pathogenic (Jul 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:161276204
- GRCh38:
- Chr1:161306414
| MPZ | G167R | Charcot-Marie-Tooth disease dominant intermediate D, Dejerine-Sottas disease, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease type 4E, Roussy-Lévy syndrome, Charcot-Marie-Tooth disease, type I | Pathogenic (Aug 27, 2021) | criteria provided, multiple submitters, no conflicts |